Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial

DiscussionThis trial will determine whether CCP will reduce intubation or death non-intubated adults with COVID-19. The trial will also provide information on the role of and thresholds for SARS-CoV-2 antibody titres and neutralization assays for donor qualification.Trial registrationClinicaltrials.govNCT04348656. Registered on 16 April 2020.
Source: Trials - Category: Research Source Type: clinical trials